请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00032
Application Flow cytometry, animal model study
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human Glycoprotein IIb/IIIa Receptor
Formulation PBS, pH 7.4

Description

Abciximab Biosimilar uses the same protein sequences as the therapeutic antibody abciximab. Abciximab, a glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor. While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug. Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.

Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody B00032

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥3250

¥3250
加入购物车
立即购买
Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody-远泰生物
请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00032
Application Flow cytometry, animal model study
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human Glycoprotein IIb/IIIa Receptor
Formulation PBS, pH 7.4

Description

Abciximab Biosimilar uses the same protein sequences as the therapeutic antibody abciximab. Abciximab, a glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor. While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug. Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.

Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody B00032

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥3250

¥3250
加入购物车
立即购买